Research, all articles

Vitamin-D and COVID-19: do deficient risk a poorer outcome

Fiona Mitchell Despite difficulties in comparing data across nations, mortality from COVID-19 is clearly higher in some countries than in others. Many factors could have a role in this disparity, including differences in proportion of elderly people in a population, general health...

Is a vitamin D fortification strategy needed?

J. L. Buttriss S. A. Lanham‐New Almost one in five adults aged 19–65 years in the UK has a low serum vitamin D concentration (below 25 nmol/l) according to the National Diet and Nutrition Survey (NDNS) (Roberts et al. 2018), which puts them at increased risk of the manifestations of...

Vitamin D and SARS-CoV-2 virus/COVID-19 disease

Lanham-New S, Webb A, Cashman K. et al. Background and aim The spread of novel SARS-CoV-2 virus, and the disease COVID-19 that is caused by SARS-CoV-2, continues apace. Saving lives and slowing the worldwide pandemic remain of utmost importance to everyone: the public, healthcare...

Maternal choline supplementation ameliorates Alzheimer’s disease pathology by reducing brain homocysteine levels across multiple generations. Velazquez R, et al. Mol Psychiatry. 2019; Epub ahead of print.

Abstract The lack of effective treatments for Alzheimer's disease (AD) is alarming, considering the number of people currently affected by this disorder and the projected increase over the next few decades. Elevated homocysteine (Hcy) levels double the risk of developing AD. Choline, a...